Characterization of antiretroviral treatment in patients with Human Immunodeficiency Virus

Leonardo Manuel Castell Martínez, José Grabiel Correa Rodríguez, Alejandro Antonio Fleitas Almirall and Rosalin Palacio Guerra

SAP Primary Care, 2026

Abstract: Introduction: Human immunodeficiency virus (HIV) infection, which causes acquired immunodeficiency syndrome (AIDS), continues to be a global health problem. Highly active antiretroviral therapy has been the most efficient public health intervention strategy for improving survival and reducing morbidity and mortality in patients with HIV. Objective: To characterize the antiretroviral treatment prescribed for patients diagnosed with Human Immunodeficiency Virus in the municipality of Manzanillo. Method: A descriptive, observational, cross-sectional study was conducted between July and November 2025. A simple random probability sampling method yielded a sample of 158 patients. Results: 75.3% of the patients were male (n=119); homosexual sexual orientation was the most frequent, and all of these individuals were male. The most representative treatment regimen was Tenofovir/Lamivudine/Dolutegravir; 67.09% of patients had an intermediate viral load. Conclusions: Male sex, homosexual orientation, and intermediate-range laboratory results predominated.

Date: 2026
References: Add references at CitEc
Citations:

Downloads: (external link)
https://southam.pub/journals/files/pc/pc202662en.pdf (application/pdf)
https://southam.pub/journals/files/pc/pc202662es.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cwf:pcarti:pc202662

DOI: 10.62486/pc202662

Access Statistics for this article

More articles in SAP Primary Care from South American Publishing
Bibliographic data for series maintained by South American Publishing Journals Manager ().